^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
anti-BCMA CAR-T cells
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Hrain Biotech
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs:
Phase 2
Hrain Biotechnology Co., Ltd.
Recruiting
Last update posted :
12/09/2022
Initiation :
07/12/2022
Primary completion :
07/31/2025
Completion :
07/31/2027
TNFA • IL2 • IL10 • CRP
|
anti-BCMA CAR-T cells
Share
